[HTML][HTML] Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review

Q Wang, J Liu, Z Chen, J Zheng, Y Wang… - Biomedicine & …, 2024 - Elsevier
Hepatocellular carcinoma (HCC) poses a heavy burden on human health with high
morbidity and mortality rates. Systematic therapy is crucial for advanced and mid-term HCC …

Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis

S Ahmed, CB Mahony, A Torres, J Murillo-Saich… - Arthritis Research & …, 2023 - Springer
Background Synovial fibroblasts in rheumatoid arthritis (RAFLS) exhibit a pathological
aberration of glycolysis and glutaminolysis. Henceforth, we aimed to investigate if dual …

Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer

D Wu, A Dasgupta, AD Read, RET Bentley… - Free Radical Biology …, 2021 - Elsevier
The homeostatic oxygen sensing system (HOSS) optimizes systemic oxygen delivery.
Specialized tissues utilize a conserved mitochondrial sensor, often involving NDUFS2 in …

Advances in Nanodelivery Systems Based on Metabolism Reprogramming Strategies for Enhanced Tumor Therapy

Z Zhang, X Liang, X Yang, Y Liu… - ACS Applied Materials & …, 2024 - ACS Publications
Tumor development and metastasis are closely related to the complexity of the metabolism
network. Recently, metabolism reprogramming strategies have attracted much attention in …

3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells

X Sun, G Sun, Y Huang, Y Hao, X Tang, N Zhang… - Biochemical …, 2020 - Elsevier
Chloroethylnitrosoureas (CENUs) are bifunctional antitumor alkylating agents, which exert
their antitumor activity through inducing the formation of dG-dC interstrand crosslinks (ICLs) …

[HTML][HTML] 3-Bromopyruvate inhibits the malignant phenotype of malignantly transformed macrophages and dendritic cells induced by glioma stem cells in the glioma …

Y Sheng, Q Jiang, X Dong, J Liu, L Liu, H Wang… - Biomedicine & …, 2020 - Elsevier
Abstract Bromopyruvate (3-BrPA) is a glycolysis inhibitor that has been reported to have a
strong anti-tumour effect in many human tumours. Several studies have reported that 3-BrPA …

The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 …

M Petricciuolo, M Davidescu, K Fettucciari, L Gatticchi… - Heliyon, 2020 - cell.com
Metabolic reprogramming of tumour cells sustains cancer progression. Similar to other
cancer cells, glioblastoma cells exhibit an increased glycolytic flow, which encourages the …

Clinical targeting of altered metabolism in high-grade glioma

AJ Scott, CA Lyssiotis, DR Wahl - The Cancer Journal, 2021 - journals.lww.com
High-grade gliomas are among the deadliest of all cancers despite standard treatments, and
new therapeutic strategies are needed to improve patient outcome. Targeting the altered …

[HTML][HTML] Construction and evaluation of folic acid-modified 3-bromopyruvate cubosomes

F Hou, H Wang, Y Zhang, N Zhu, H Liu… - Medical Science Monitor …, 2020 - ncbi.nlm.nih.gov
Background Direct 3-bromopyruvate chemotherapy often causes side effects. We thus
aimed to construct and evaluate folic acid-modified 3-bromopyruvate liquid crystalline …

葡萄糖代谢重编程在肿瘤基础研究及临床诊疗中的研究进展

江圆, 陈亚, 谢杨阳, 黄信羽, 赵健, 梁蓓蓓 - 肿瘤防治研究, 2021 - zlfzyj.com
摘要肿瘤通过葡萄糖代谢重组为自身提供物质与能量, 满足其快速增长所需.
研究表明参与葡萄糖代谢过程中的多种代谢酶及信号分子在肿瘤发生, 发展中发挥着重要作用 …